Rick Simpson Oil (RSO) in Lowndes County, Georgia: The Complete Guide by OilWell Cannabis

If you’re reading this in Lowndes County, you’re probably somewhere between Valdosta and Moody Air Force Base, maybe out near Lake Park or Hahira, and you’ve got questions about Rick Simpson Oil that deserve real answers—not hype, not promises, just the truth about what RSO is, what it can and can’t do, and how our formulas are different from anything else you might find in South Georgia. We wrote this because folks in Lowndes County deserve the same depth of information that patients in Houston’s Texas Medical Center get, whether you’re dealing with chronic pain from working the cotton fields, supporting a loved one through cancer treatment, or trying to help a veteran from Moody AFB manage PTSD. Let’s start at the beginning.

About Rick Simpson and Traditional RSO: The Story That Reached Lowndes County

Who Is Rick Simpson, and Why Does He Matter to Georgia?

Rick Simpson wasn’t a doctor. He wasn’t a scientist. He was a power engineer from Nova Scotia—a working-class tradesman, not unlike many folks in Lowndes County who’ve spent decades in agriculture, manufacturing, or at the base. In 1997, while working at a hospital in Moncton, he fell from scaffolding and suffered a serious head injury. The aftermath—persistent tinnitus, dizziness, post-concussion symptoms—was brutal. Conventional medicine gave him prescriptions that didn’t work or made things worse. When he asked his doctor about cannabis, the doctor refused. Sound familiar? We’ve heard similar stories from Lowndes County residents who’ve been told “no” by doctors who won’t consider cannabis, even as Georgia’s restrictive Low THC Oil Registry leaves many patients without options.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study was never replicated in controlled human cancer trials, but it became the spark that lit the RSO movement .

The pivotal moment came in 2003. Simpson claimed three bumps on his arm were diagnosed as basal cell carcinoma. Instead of conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification, no biopsy confirmation, no clinical follow-up has ever been published in any peer-reviewed source. This is personal testimony, not medical evidence—but it is historically significant as the catalyst for a global movement .

The Crusade: How RSO Became a Household Name in Places Like Lowndes County

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil—for free. He gave it away to cancer patients and anyone in his community dealing with chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more. No charge. No profit. He claimed to help dozens, maybe hundreds .

His story reached the world through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film was distributed freely online and became foundational in cannabis communities. For many people—maybe including some folks in Lowndes County who first heard about RSO through online forums or patient support groups—Run From The Cure was their introduction to concentrated cannabis oil as medicine .

But Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad .

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his primary platform .

His Claims vs. The Evidence: What Lowndes County Residents Need to Know

Simpson consistently claimed RSO could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as fighting institutional corruption .

What Simpson was not: He had no formal training in medicine, oncology, pharmacology, or clinical research. He never conducted or published a trial. His evidence base consisted of personal experience and testimonials gathered informally—no controls, no independent verification, no blinding .

What the preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition .

What the preclinical literature does not show: These findings have not translated into proven human cancer cures. The gap between animal results and human outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer .

Institutional positions:

• The U.S. National Cancer Institute acknowledges anticancer research in labs and animals but does not endorse cannabis oil as cancer treatment .
• The FDA has not approved any cannabis plant product for cancer. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol/nabilone) have specific FDA approvals—for seizures, chemo nausea, and HIV/AIDS wasting [1].
• Health Canada has never approved RSO for cancer .
• NCCIH states the strongest cannabinoid evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world was ignoring it. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract .

What he overstated: The leap from preclinical signals to cancer cure was not supported then and is not supported now. Encouraging patients—especially cancer patients—to rely on RSO as primary treatment in place of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern .

This matters deeply in Lowndes County, where cancer patients may face long drives to treatment centers in Valdosta or Macon, and where the temptation to try “natural cures” can be strong. We believe you deserve honesty over false hope.

The Legacy: How “RSO” Became a Generic Term in Georgia Dispensaries

The term RSO is now used broadly and loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to what Simpson made. In dispensaries—where they exist in legal states—RSO can refer to almost any full-spectrum extract in a syringe, regardless of extraction method or cannabinoid profile .

Simpson himself has criticized commercial products that use the RSO name while departing from his method. He believed in a DIY, free-access model. The modern industry has commercialized, standardized, and regulated what he gave away. Whether that’s improvement (quality control, lab testing) or betrayal (profit extraction) depends on perspective .

What is not disputed is that modern RSO has evolved substantially. That evolution is directly relevant to what we offer Lowndes County.

Traditional RSO vs. Modern Formulated RSO: A Comparison for Lowndes County Consumers

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No—fully decarboxylated by heat	Yes—THCa included as separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why Our Formulas Diverge from Traditional RSO

Our formulations are informed by the RSO tradition but depart deliberately in evidence-motivated ways that matter for Lowndes County residents:

• Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

• Terpene preservation and addition. Traditional RSO had essentially no terpene content due to solvent and heat destruction. We include live terpenes at 5% with a specific seven-terpene profile—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—because terpene bioactivity is plausible at the preclinical level, even if robust human confirmation remains limited [20]-[29].

• THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity lost when THCa converts to THC [12].

• Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC—60 to 90% of total cannabinoids. Our sublingual formula uses delta-9 THC at only 90 mg while distributing content across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), CBN (750 mg), and CBC (750 mg). This reflects broader cannabinoid research rather than single-compound dominance.

• Product format innovation. Simpson envisioned only oral oil from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulation acknowledging different pharmacokinetic profiles [14].

Solvent Safety: Why Lowndes County Residents Should Care

Traditional RSO production used naphtha or isopropyl alcohol—neither food-grade. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues in finished oil. Modern extraction uses food-grade ethanol or supercritical CO₂ with validated analytical testing. This is one of the most straightforward improvements the modern regulated industry has made over traditional RSO [1][10][11][14].

For Lowndes County residents considering DIY extraction—perhaps because Georgia’s medical program is so restrictive—understanding solvent risk is critical. We’ve seen home extraction accidents in rural areas. OilWell’s approach eliminates this risk entirely: no solvents in finished product.

The Decarboxylation Choice: Patient-Controlled Potency for Lowndes County

Traditional RSO was always fully decarboxylated. The heat evaporated solvent and converted all THCa to delta-9 THC, leaving patients no choice about psychoactivity.

Our sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three usage options:

Option 1—Raw, no heat. All 1,500 mg stays as THCa—completely non-psychoactive. The THCa evidence profile suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with work, driving, and daytime use with zero impairment—crucial for Lowndes County residents who operate farm equipment, work at Moody AFB, or commute long distances.

Option 2—Fully activated, home decarboxylation. Heating oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg THCa to approximately 1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, this yields approximately 1,405 mg total delta-9 THC—giving psychoactive potency comparable to traditional illegal RSO, 100% legally, because decarboxylation occurs after purchase. You can also transfer a controlled portion to a second oven-safe container, decarboxylating only what you intend to use while preserving the remainder raw.

Option 3—Vape, auto-decarboxylation. Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids—fastest-onset RSO delivery method available.

Conversion chemistry: THCa molecular weight is 358.47 g/mol. Approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting CO₂ loss during reaction.

This design puts potency control entirely in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

Terpene Loss in Traditional RSO vs. Our Approach

Terpenes are volatile aromatic compounds with low boiling points (21-157°C). Traditional RSO’s high-heat solvent evaporation destroyed terpenes completely. Whatever aromatic or bioactive compounds the source cannabis contained were lost.

Our formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has its own evidence profile in our GENERAL KNOWLEDGE section. The entourage-effect literature provides theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically, even though robust human proof remains limited [20][29].

Evidence Standards: Then and Now

Rick Simpson operated pre-legalization, pre-testing—an era when cannabis was illegal, no regulatory framework existed, and personal experience was the only evidence currency. His evidence was anecdotal; his production was unstandardized; his claims were untested .

This document takes a fundamentally different approach. Our GENERAL KNOWLEDGE section applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29]. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled.

Where Simpson relied on personal testimony, we rely on published literature. Where Simpson made absolute claims, we tell you what is well-supported, what is emerging, and what is overstated. That honesty is what Lowndes County residents deserve when making decisions about their health.

Simpson’s Protocol vs. Modern Dosing: Why Lowndes County Residents Must Understand the Difference

Simpson’s 60-gram/90-day protocol was designed for crude, single-strain, variable-potency extract. Direct comparison with our standardized, multi-cannabinoid formulation is not straightforward—the products are fundamentally different.

Key differences:

• Cannabinoid concentration: Our sublingual formula delivers 553 mg total cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• Cannabinoid ratios: Simpson’s oil was 60-90% delta-9 THC. Our formula distributes 16,590 mg across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), CBN (750 mg), CBC (750 mg), and only 90 mg delta-9 THC.
• Delta-9 THC exposure: Simpson’s peak dosing delivered approximately 600-900 mg delta-9 THC daily. Our entire 30 mL bottle contains only 90 mg delta-9 THC (3 mg/mL). Per-dose exposure is dramatically lower.

For Lowndes County residents, this means you cannot apply Simpson’s protocol to OilWell products. Our dosing guidance must be developed independently, informed by per-compound evidence and responsible titration principles.

About OilWell Cannabis and Our RSO Formula: Bringing Houston-Made Quality to Lowndes County

Our Origin: From McAllen to Moody AFB’s Backyard

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas—right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts—vibrant culture and retail, yet deeply affected by poverty and limited opportunities. Reynosa is an industrial hub plagued by violence and cartel activity.

Colin’s childhood was marked by exposure to both opportunities and challenges. Early on, he learned to hustle, taking on risky work transporting items across the border. He experienced every form of violence imaginable. By sixteen, he had to leave home for good. Many of his best friends have been killed or are in prison because of those associated dangers.

Despite the dangers, Colin didn’t fall into darker paths. He focused on cannabis, seeing it as a safer, more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. He transitioned from risky ventures to creating a legal, legitimate business in an industry he believes in.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines our approach.

Bentley’s Story: The Foundation That Reaches Lowndes County Veterinarians

Our company’s origin begins with a dog named Bentley. Bentley was more than a pet—he was family. When he fell seriously ill, veterinarians delivered the worst news: euthanasia was the only humane option. Bentley was paralyzed in his back legs. Pain medications would destroy his internal organs, causing more suffering. The choice was prolonged decline or immediate mercy.

But giving up wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought his ball to play. From paralyzed and facing euthanasia to fetching his ball. This wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene simultaneously.

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork. That same precision is what we bring to Lowndes County residents today.

Colin’s Personal Battle: PTSD, Benzo Addiction, and the Formulas That Saved Him

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a notoriously difficult and dangerous feat—using the cannabinoid knowledge he’d developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Many veterans from Moody AFB face similar battles. The VA system often prescribes benzodiazepines for PTSD, creating dependency cycles. Our formulas were born from someone who escaped that cycle and built a company to help others do the same.

Doctors Use Our Formulas: From Crohn’s to Diabetes

Over time, the therapeutic benefits Colin discovered through Bentley became the core of our work. We’ve developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

In Lowndes County, where access to specialists can be limited and integrative medicine options are scarce, having a product line that physicians trust matters. Our formulas aren’t just theoretical—they’re used in clinical contexts where conventional medicine falls short.

ABC13 Houston: Seven Features Proving Our Credibility

Between September 2019 and April 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth during the same period.

These features aren’t marketing materials. They’re independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin as the most credible, quotable, accessible voice in Houston’s legal cannabis industry. That recognition cannot be purchased—it can only be earned.

Feature 1: Texas CBD Business Boom (September 15, 2019)

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Feature 2: Decriminalization Efforts (March 22, 2021)

Colin’s therapy quote: “Pain comes in a lot of different forms.” This segment positioned us as ecosystem builders helping other entrepreneurs enter legal cannabis.

Feature 3: Delta-8 THC Investigation (May 24, 2021)

Steve Campion’s iconic exchange:

• Campion: “Why would someone want to smoke that?”
• Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

Radical honesty on mainstream TV. The segment balanced our unapologetic stance with medical caution from UTHealth’s Dr. Michael Weaver and regulatory advocacy from Heather Fazio of Texans for Responsible Marijuana Policy.

Feature 4: COVID Vaccine Giveaway (August 20, 2021)

We gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage vaccination. We coordinated with the city of Houston. No political agenda—just community health action.

Feature 5: Delta-8 Ban Impact (October 19, 2021)

When Texas DSHS classified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement began. Colin warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed major revenue loss to act ethically.

Feature 6: Biden Marijuana Pardon (October 7, 2022)

This feature revealed Colin’s personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything.” He also said: “I would love to see people not get hurt for this anymore.”

This personal history transforms our entire media record—every quote about therapy, education, and integrity carries additional weight when you understand the person saying it has lived the consequences of cannabis criminalization.

Feature 7: 4/20 Industry Renaissance (April 21, 2023)

Colin’s “Renaissance” framing: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.” The feature documented us growing hemp on camera and positioned OilWell at the frontier of legal cannabis innovation.

Our Philosophy: Four Principles for Lowndes County

Our RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing deliberately:

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally. Simpson believed medicine should be accessible; we built a model that makes it legally accessible to Lowndes County.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish complete formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away free; we adapted that ethos for the modern marketplace.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what is well-supported from what is overstated.

Farm Bill Compliance: How Our THCa Framework Protects Lowndes County Customers

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 mg delta-9 THC in the entire 30 mL bottle—3 mg/mL—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most states, including Georgia.

THCa is the key. THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

The practical significance for Lowndes County residents is substantial. You can legally purchase, possess, and transport our product, then decarboxylate THCa into delta-9 THC at home by heating oil at 260°F (125°C) for 45-60 minutes. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, this produces ~1,405 mg total delta-9 THC—giving psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal risk.

Open-Source Formulas: The Bentley Recipe and Why It Matters for Lowndes County

We publish our complete RSO formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford our products can source ingredients and make their own.

This is a direct echo of Rick Simpson’s ethos. Simpson gave his oil away free; we adapted that for the modern marketplace.

Our open-source philosophy started with Bentley. On our About Us page, we published the actual CBD golden paste recipe that saved Bentley’s life, so any pet owner facing a similar crisis could make it:

CBD Golden Paste Recipe for Pets (Original Open-Source Formula)

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in jar with lid. Refrigerate up to two weeks.
4. Add small amount of CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs. Start low and increase gradually.

Serving: Mix small amount with pet’s food once or twice daily. Monitor for changes. Consult veterinarian before starting any supplement regimen.

For Lowndes County pet owners—whether you’re caring for a working dog on your farm or a family companion in Valdosta—this recipe is free, it’s useful, and it demonstrates our character.

The Decarboxylation Choice: Three Options for Lowndes County Lifestyles

Our sublingual formula creates three distinct usage paths:

Option 1—Raw, no heat (Daytime Functional). All 1,500 mg stays as THCa—completely non-psychoactive. Supports anti-inflammatory and neuroprotective pathways without impairment. Perfect for Lowndes County residents who operate farm equipment, work security at Moody AFB, or drive long distances for work.

Option 2—Fully activated (Nighttime Therapeutic). Home decarboxylation converts THCa to delta-9 THC, delivering ~1,405 mg total delta-9 THC for full psychoactive potency. Ideal for evening use when impairment isn’t a concern.

Option 3—Vape cartridge (Fast Relief). Instant decarboxylation at 400-450°F delivers freshly activated cannabinoids in 1-2 minutes. Perfect for breakthrough pain, panic attacks, or acute nausea.

Solvent-Free Production: Safety for Lowndes County Families

Our RSO isn’t an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled environment. No naphtha. No isopropyl alcohol. No butane.

We use organic MCT oil as the carrier base—a food-grade lipid that facilitates sublingual absorption and provides neutral taste, a massive improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and through our website.

Beyond RSO: Our Broader Portfolio for Lowndes County Needs

Asshole Peach — Our most popular product, particularly favored by veterans for PTSD and pain relief. A carefully formulated experience designed for euphoric, long-lasting sensation.

Peace Gummies — Developed from Colin’s personal benzo withdrawal experience. Available in gummy and vape forms for quick relief. Many Moody AFB veterans use this for sleep and anxiety.

Custom Creations — We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances. Whether you’re a vegan in Lake Park, a diabetic in Hahira, or someone with unique dietary needs in Valdosta, we can formulate for you.

Two Product Formats: Which Works for Your Lowndes County Life?

RSO Sublingual Oil — $129.99

• 30 mL bottle, 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1 mL increments)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge, 900+ mg total cannabinoids
• Six cannabinoids: CBD 30%, CBG 20%, delta-8 THC 15%, THCa 10%, CBN 10%, CBC 10%
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest method)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylates THCa at vaping temperature

When to Use Each Format: A Lowndes County Guide

Use Case	Recommended Format	Why It Works for Lowndes County
Fast relief (acute pain, panic, nausea)	Vape	1-2 minute onset—crucial for breakthrough moments
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration—covers overnight or work shift
Maximum bioavailability	Sublingual	13-19% absorption—more cannabinoids reach bloodstream
Portability/discretion	Vape	Compact, no measuring—fits in pocket for on-the-go
Precise dosing control	Sublingual	Graduated dropper—critical for titration
Daytime non-psychoactive	Sublingual (raw)	Zero impairment—drive, work, parent safely
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full activation for sleep and deep relief

Condition-Specific Usage Context for Lowndes County Residents

Important Disclaimer: These contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For Lowndes County cancer patients traveling to treatment centers in Valdosta, Macon, or Jacksonville:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 antiemetic [9], delta-9 nausea [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

For Lowndes County’s agricultural workers, warehouse employees, and veterans:

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed
• Evidence: CBD pain [4], delta-9 THC pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

For insomniacs across Lowndes County:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: 50 mg CBN—dosage level investigated in 2024 sleep literature
• At 1.0 mL: 25 mg CBN—above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep [16][17]

Anxiety and Stress

For Moody AFB veterans, first responders, and stressed families in Lowndes County:

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Global Accessibility: Getting RSO to Lowndes County

Nationwide Shipping to Lowndes County

We ship to all 50 states where Farm Bill-compliant products are legal, including Georgia. For Lowndes County residents:

• USPS Priority Mail: 2-3 business days to Valdosta, Lake Park, Hahira, and surrounding areas
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible—important in a community where privacy matters
• Tracking: Provided for all orders
• Temperature-stable packaging: Critical for Georgia’s hot summers
• Signature-required option: Available for added security

International Shipping

We’ve delivered to multiple countries across continents. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at point of sale, it meets hemp product definitions and is shippable to jurisdictions with compatible hemp laws.

All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs. Minimum flat-fee shipping applies; excessive costs are billed to the customer. The customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk.

PANDEM1C SEO Technology

Our proprietary system with 14 million distinct geopolitical locations and over 300 AI models drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language. Lowndes County residents searching in English or Spanish can find us easily.

How Our Formulas Connect to Evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field. Where we make specific research claims, this document provides source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework.

Our position, as stated in that 2019 ABC13 interview that started our media record, is that people deserve the best possible version of information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

We are more than a brand. We are a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

Media Recognition and Community Impact: Why ABC13 Houston Trusts Us

General Knowledge: The Science Behind Every Compound in Our Formula

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. This weighting matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and in vitro pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states the strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss. The FDA has not approved the cannabis plant itself for medical use, though purified CBD (Epidiolex) and synthetic THC analogues (dronabinol/nabilone) have specific approvals [1].
• Safety concerns repeatedly highlighted include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination/labeling inaccuracy, and THC-vape lung injury [1].
• NCCIH warns that over-the-counter CBD products may differ from labels and that CBD itself is associated with decreased alertness, GI effects, liver-related adverse effects, and drug interactions [1].

Cannabinoid Profiles

CBD: Strongest human evidence in our formula set. Best supported for seizure disorders [1][2]. A 2024 systematic review found significant anxiolytic signal but stressed limited clinical sample [3]. A 2024 pain review found promising but heterogeneous literature [4]. A 2023 insomnia review found methodologically weak studies [5]. A 2023 review found real signal for liver enzyme elevation and possible drug-induced liver injury [6]. Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications, not broad wellness claims [1]-[6].

CBG: Mostly review-level and preclinical; human evidence sparse [7][8]. Pharmacology includes cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7]. Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses [7][8]. Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11]. 2022 review concluded broadly similar pharmacokinetic/pharmacodynamic behavior to delta-9, but less potent due to weaker CB1 affinity [9]. 2023 scoping review found evidence base dominated by animal studies and public health concerns rather than strong human trials [10]. Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa: Important chemically but low on direct human therapeutic evidence [12]. Itself does not produce psychoactive effects, but decarboxylation converts it to THC [12]. In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not established human outcomes [12]. Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, and storage [12].

Delta-9 THC: Strongest human evidence of psychoactive cannabinoids listed, but clearest adverse-effect burden [1][13]-[15]. NCCIH identifies relevance to chemo nausea, HIV/AIDS appetite, and some MS/pain outcomes [1]. 2022 chronic pain review found high-THC products may provide short-term benefit but increase dizziness, sedation, nausea, and discontinuation [13]. Classic pharmacokinetics: inhaled onset seconds-minutes, oral onset later with longer duration [14]. 2025 review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder at high concentrations [15]. Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN: Weak human evidence; marketing ahead of data [12][16][17]. Best review found no clinical trials using validated sleep questionnaires or polysomnography to substantiate sleep-promoting claims [16]. 2024 sleep review concluded overall cannabinoid sleep research doesn’t match real-world use scale [17]. Bottom line: Clearest example where cultural reputation is stronger than clinical evidence [16][17].

CBC: Emerging, intriguing, overwhelmingly preclinical [18][19]. 2024 review describes distinct pharmacodynamics/pharmacokinetics, highlighting antinociceptive, antibacterial, and anti-seizure as interesting research targets [18]. Older literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, and possible neurobiological/antiproliferative relevance, but not strong evidence for patient claims [19]. 2024 review explicitly notes over-the-counter CBC products being sold despite little evidence establishing clinical efficacy or safety [18]. Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Profiles

Limonene: Largely review and preclinical [20]-[22]. 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities, but mostly from nonhuman/non-cannabis literature [21]. Oxidation products are clinically relevant contact allergens [22]. Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene: Mostly preclinical, very limited human evidence [20][23]. 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but explicitly states human studies lacking [23]. Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene: Among most mechanistically interesting due to direct cannabinoid-system relevance [24]. 2021 review describes as selective CB2 receptor agonist, making it especially relevant pharmacologically [24]. Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions discussed, but human clinical confirmation limited [24]. Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but still shouldn’t be described as clinically proven [24].

Pinene: Promising preclinical literature, weak human confirmation [20][25]. 2021 review on pinene and linalool found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized well-designed clinical trials lacking [25]. Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. 2021 brain-health review found enough preclinical signal to justify continued investigation, but lack of robust human trials [25]. Separate review discusses possible antidepressant mechanisms, but remains translational rather than definitive [26]. Oxidized linalool hydroperoxides are recognized allergens [22]. Bottom line: Scientifically credible bioactive terpene, but compound-specific human therapeutic claims should be made carefully [22][25][26].

Humulene: Translationally interesting but early [20][27]. 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]. Bottom line: More interesting terpene research target, but far from clinically settled [27].

Terpinolene: Least clinically characterized in this file [20][28]. 2021 systematic review screened 2,449 records, included 57 studies, concluding evidence base dominated by in silico, in vitro, and animal studies rather than human trials [28]. Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract, purified-molecule, semisynthetic cannabinoid, and terpene-only data are not interchangeable.
• Minor cannabinoids and terpenes are commercially interesting because they’re underexplored, but claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics materially affect real-world interpretation [1][10][11][14].
• THCa chemistry changes with storage and heating. Storage and heating can convert acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid (And What to Say Instead)

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• CBD and delta-9 THC are most evidence-developed actives.
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC.
• THCa changes significantly with processing.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC.
• Terpene claims should be careful and conservative.

References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

RSO Sublingual Oil Formula

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total Cannabinoids	16,590

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper in 0.1 mL increments
• Onset: 15-45 minutes sublingual
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: ~40-60 depending on serving size
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• 510-thread: Universal battery compatibility
• Onset: 1-2 minutes (fastest method)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation: Converts THCa to delta-9 THC at 400-450°F
• Price: $49.99

Terpene Profile (Both Products)

• Limonene: Citrus-bright aroma, potential mood support
• Myrcene: Earthy foundation, relaxation properties
• Caryophyllene (β-caryophyllene): Pepper/spice, CB2 agonist
• Pinene: Forest-fresh, clarity support
• Linalool: Floral, lavender, calm support
• Humulene: Earthy, woody, inflammation pathways
• Terpinolene: Piney, fruity, sparkling complexity

How to Order RSO in Lowndes County

Ready to try our RSO formulas? Here’s how easy it is for Lowndes County residents:

1. Visit our website: OilWell Cannabis RSO Guide
2. Choose your format: Sublingual oil for sustained relief or vape cartridge for fast-acting support
3. Place your order: We accept all major payment methods
4. We ship to your Lowndes County address: USPS Priority Mail (2-3 days) or FedEx/UPS Ground (3-5 days)
5. Receive discreet, temperature-stable packaging: No external cannabis branding, protected from Georgia heat
6. Access your COA: Certificate of Analysis available online or by request
7. Start low, go slow: Begin with 0.25-0.5 mL and assess effects over 2-3 hours

For Moody AFB veterans and active duty: We ship to base addresses. Our products are Farm Bill compliant and contain less than 0.3% delta-9 THC at point of sale. However, we encourage you to understand your service branch’s policies regarding hemp-derived products and drug testing.

Questions? Contact us directly:

• Phone: (832) 416-2816
• Email: [email protected]
• Hours: Monday-Thursday 10 AM-7 PM, Friday-Saturday 10 AM-10 PM, Sunday 10 AM-4 PM (Central Time)

Final Thoughts for Lowndes County

We wrote this guide because you deserve more than marketing fluff. Whether you’re in Valdosta dealing with chronic pain from decades of physical work, in Lake Park supporting a family member through chemotherapy, at Moody AFB managing PTSD, or anywhere in Lowndes County simply curious about cannabinoid science—we believe informed decisions require complete information.

Our formulas are published openly because Simpson taught us that medicine should be accessible. Our evidence is documented thoroughly because you deserve to know what’s proven, what’s promising, and what’s overstated. Our products are manufactured with precision because Bentley’s life depended on it, and so might yours.

Lowndes County residents don’t need snake oil. You need honest education, safe products, and the freedom to control your own wellness journey. That’s what we offer.

Order today: OilWell Cannabis RSO Products

Age requirement: 21+ only

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use.

Safety Warning: May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Keep out of reach of children. If pregnant or nursing, consult a physician before use.

Legal Responsibility: Buyer is responsible for checking local laws. Company assumes no legal responsibility for customer’s use or decarboxylation decisions. Void where prohibited by law.